CARDINAL HEALTH INC's ticker is CAH and the CUSIP is 14149Y108. A total of 935 filers reported holding CARDINAL HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARTINGALE ASSET MANAGEMENT L P | 308,909 | $26,819,480 | 0.56% |
| Columbus Macro, LLC | 15,295 | $1,327,875 | 0.56% |
| JEPPSON WEALTH MANAGEMENT, LLC | 14,038 | $1,218,773 | 0.56% |
| Guardian Wealth Advisors, LLC | 8,318 | $722,176 | 0.55% |
| HF Advisory Group, LLC | 8,474 | $735,698 | 0.55% |
| Weaver C. Barksdale & Associates, Inc. | 7,307 | $634,394 | 0.54% |
| Advisors Preferred, LLC | 19,134 | $1,652,794 | 0.54% |
| ProShare Advisors LLC | 1,982,493 | $172,120,042 | 0.54% |
| Portman Square Capital LLP | 246,100 | $21,366,402 | 0.53% |
| Arjuna Capital | 16,702 | $1,450,068 | 0.52% |
| LSV ASSET MANAGEMENT | 2,509,892 | $217,909 | 0.51% |
| Glenview Capital Management | 257,330 | $22,341,391 | 0.51% |
| Legacy Capital Group California, Inc. | 13,195 | $1,145,590 | 0.49% |
| AXQ CAPITAL, LP | 15,500 | $1,345,710 | 0.47% |
| MQS Management LLC | 8,860 | $769,225 | 0.47% |
| TOEWS CORP /ADV | 8,900 | $772,698 | 0.47% |
| Meiji Yasuda Asset Management Co Ltd. | 112,635 | $9,778,971 | 0.46% |
| Camelot Portfolios, LLC | 5,500 | $477,510 | 0.46% |
| 1834 INVESTMENT ADVISORS CO | 41,725 | $3,622,565 | 0.45% |
| AQR Capital Management | 2,496,531 | $216,748,752 | 0.45% |
About CARDINAL HEALTH INC
Cardinal Health Inc. is a leading healthcare services and products company that provides pharmaceuticals, medical products, and services to hospitals, pharmacies, and healthcare providers. The company operates in two segments: Pharmaceutical and Medical.
The Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals, over-the-counter healthcare products, and consumer health products. The Medical segment distributes medical, surgical, and laboratory products to hospitals, surgery centers, and physician offices.
Cardinal Health has a strong presence in the United States and operates in over 60 countries worldwide. The company has a market capitalization of over $15 billion and employs over 50,000 people.
In recent years, Cardinal Health has focused on expanding its product offerings and services to meet the changing needs of the healthcare industry. The company has made several strategic acquisitions, including the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses.
Cardinal Health has also been recognized for its commitment to sustainability and corporate responsibility. The company has been named to the Dow Jones Sustainability Index for the past 10 years and has received numerous awards for its environmental and social initiatives.
Overall, Cardinal Health is a well-established and respected player in the healthcare industry, with a strong track record of growth and innovation. As the healthcare landscape continues to evolve, Cardinal Health is well-positioned to continue delivering value to its customers and shareholders.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists CARDINAL HEALTH INC's shareholders in Q3 2023. To view CARDINAL HEALTH INC's shareholder history, click here.